Drug Combination Details
| General Information of the Combination (ID: C43091) | |||||
|---|---|---|---|---|---|
| Name | Triamcinolone NP Info | + | 5-fluorouracil Drug Info | ||
| Structure |
|
+ |
|
||
| Disease |
Keloidscars
[ICD-11: N.A.]
|
Phase 4 | [1] | ||
|
Keloids
[ICD-11: EE60]
|
Investigative | [2] | |||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [2] | |||||
| Molecule(s)
Regulation |
Down-regulation | Expression | COL1A1 | Molecule Info |
Pathway MAP
|
|
| Down-regulation | Expression | TGFB1 | Molecule Info |
Pathway MAP
|
||
| Biological
Regulation |
Induction | Cell cycle arrest in G2 phase | ||||
| In-vitro Model | Keloid fibroblasts | Healthy | Homo sapiens | |||
| Experimental
Result(s) |
Combination of TA and 5-FU showed synergistic interation in regulating the biological behaviour of keloid fibroblasts in vitro. | |||||